242 Chapter 8 · Clinical Features and Natural History of AMD on OCT
CLINICAL CASE No. 08: Mixed (Classic and Occult) CNV of Equal Dimensions
Follow-Up after Treatment
The response to treatment of monthly intravitreal injections of anti-VEGF (Lucentis*) was monitored with visual acuity, OCT, fluorescein angiography, and ICG angiography.
Each injection was administered as indicated, which was followed by an immediate and dramatic improvement in retinal architecture (Figure 33).
After the first injection, visual acuity was moderately improved but with a marked improvement of visual symptoms.
8
OCT
By the first examination, dramatic improvement was demonstrated, with reduction of retinal thickness and a complete and rapid resolution of the large foveal and juxtafoveal intraretinal cysts.
On the horizontal section, resolution of intraretinal fluid and restoration of a normal and symmetrical foveal depression.
The inner and outer retinal layers became clearly visible. The outer nuclear layer was constantly visible and was only thinned over the classic CNV. The external limiting membrane was distinguishable with a normal appearance.
The only residual sign after resolution of classic CNV was the localized zone of hyper-reflectivity between the external limiting membrane and the IS/OS interface with thickening of the IS/OS interface (Figure 33).
In the inferior part of the vertical section, persistence of the vascularized PED still extended as far as the foveal region, but with a normal appearance of retinal layers.
Fluorescein Angiography and ICG Angiography
On fluorescein angiography, classic CNV regressed immediately with only minimal fluorescein leakage.
ICG angiography showed low perfusion of the classic CNV, but the occult CNV remained clearly visible and appeared to have become larger, justifying a second IVT injection.
Six Months Later
The situation remained stable and did not warrant any further IVT injections. VA had improved to 20/32.
Spectralis* OCT examinations confirmed resolution of intraretinal fluid and normalization of outer retinal layers.
Only the persistence of a hyper-reflective band anterior to the RPE suggested residual fibrosis of classic CNV.
The external limiting membrane was clearly visible with no hyper-reflective bright spots (Figure 34).
However, the vertical section showed a wavy, irregular, and relatively flat residual PED with a moderately reflective cavity, suggesting partial organization.
The external limiting membrane was normal but several irregularities were visible in the outer nuclear layer, which was thinned over the dome of the PED.
Autofluorescence photographs showed persistence of a superior temporal lesion but sparing the central macula.
Angiography confirmed the stabilized and scarred appearance of the lesion (Figure 34).
At this Stage |
tion of visual acuity to 20/50 then to 20/32, which |
This mixed lesion comprising an extensive subfo- |
remained stable on several successive examinations |
veal vascularized pigment epithelium detachment |
and for more than 6 months after the last injection. |
and a zone of classic choroidal neovascularization |
Suspension of treatment is only temporary and pro- |
appeared to be stabilized with good VA. This im- |
longed monitoring is essential. |
provement justified suspension of IVT injections |
|
( |
Figure 34 |
). |
The course can be easily assessed by the automatic |
|
|
|
retinal thickness (and volume) graph technique com- |
This subjective and objective improvement was ob- |
paring the same site to the initial examination using |
tained rapidly, by the first injection, with restora- |
the eye-tracking system. |
|
|
|
|
Chapter 8 · Clinical Features and Natural History of AMD on OCT |
243 |
8 |
|
|
|
|
CLINICAL CASE No. 08: MIXED (CLASSIC AND OCCULT) CNV OF EQUAL DIMENSIONS
Follow-up after treatment
Regression of Classic CNV |
2 months later |
Horizontal section |
Residual V-PED
Æ Second IVT
Vertical section
Residual V-PED
Figure 33: Mixed (classic and occult) CNV of equal dimensions of equal dimensions. Two months after the first IVT injection.
VA: 20/50.
Spectralis* horizontal and vertical sections correlated with color fundus photographs and angiography: rapid regression of classic CNV and fluorescein leakage with persistence of the occult CNV.
Spectralis* horizontal section : dramatic improvement, with regression of intraretinal fluid and cysts, normal appearance of the outer nuclear layer and external limiting membrane; persistent thickening of the IS/OS interface over the site of the classic CNV.
Spectralis* vertical section: persistence of the flatter vascularized PED, which extends subfoveally. Normal appearance of the outer layers and foveal region.
244 Chapter 8 · Clinical Features and Natural History of AMD on OCT
CLINICAL CASE No. 08: : MIXED (CLASSIC AND OCCULT) CNV OF EQUAL DIMENSIONS
|
6 month follow-up after treatment |
|
Autofluo |
SLO-ICG |
SLO-ICG |
6 month later
External limiting membrane
8
Dense area
Residual PED
Figure 34: Mixed (classic and occult) CNV of equal dimensions. 6 months later. VA: 20/32.
Spectralis* horizontal and vertical sections correlated with autofluorescence images and SLO-ICG angiography resolution of all CNV with persistence of an inferior draining vessel (arrow).
Spectralis* horizontal section (black and white and color): confirmation of resolution of intraretinal fluid and normal appearance of the outer layers despite persistence of a hyper-reflective band, suggesting residual fibrosis of classic CNV. The external limiting membrane is clearly visible. Note also regression of bright hyper-reflective spots.
Spectralis* vertical section: persistence of a residual, wavy, irregular, and partially organized PED with almost complete resolution of its superior extension. Several irregularities of the outer nuclear layer over the dome of the PED.
Chapter 8 · Clinical Features and Natural History of AMD on OCT |
245 |
8 |
|
|
|
|
CLINICAL CASE No. 08: : MIXED (CLASSIC AND OCCULT) CNV OF EQUAL DIMENSIONS
2-month follow-up after treatment
a |
2nd month after treatment |
b |
c |
|
Figure 35: Mixed (classic and occult) CNV of equal dimensions. Two months after the first IVT injection. VA: 20/50.
Demonstration of retinal thickness variations related to regression of classic CNV and the associated fluorescein leakage:
a): ICG angiography. b): Spectralis* horizontal section with contouring of the inner profile (red) and outer profile (including the RPE) (green). c): ETDRS target with thickness figures in 9 sectors. d): Overlay of the target onto the fluorescein angiography image. e): Automatic graphic comparison of retinal thickness compared to the same site as the initial examination by means of the eye-tracking system. f): False color ETDRS target showing the normal appearance of the macula and persistence of the inferior temporal lesion.
c
Figure 36: Mixed (classic and occult) CNV of equal dimensions. Six months later. VA: 20/32.
a): ICG angiography. b): Spectralis* horizontal section. c): Automatic graphic comparison of retinal thickness compared to the same site as the initial examination.
246 Chapter 8 · Clinical Features and Natural History of AMD on OCT
CLINICAL CASE No. 09: Progressive Proliferation of Occult CNV
Occult CNV gradually deteriorating and recurring on an old laser scar.
Follow-up by TD-OCT and SD-OCT after anti-VEGF therapy
Clinical Signs
A 73-year-old man was followed for wet AMD of his left eye, which had been treated by PDT.
Autofluorescence showed a fairly large but regular perimacular halo of hyper-fluorescence (Figure 37a and b).
Fluorescein angiography (Figure 37c and d):
In the absence of symptoms and with normal visual acuity, routine assessment of the right eye demonstrated the presence of an extrafoveal area of classic choroidal neovascularization measuring 1 DD, more than 1500 μm from the center. This lesion was successfully treated by a single session of thermal laser, without recurrence and
8with a good scar that remained stable for half a year.
After about 6 months, the patient reported slowly progressive visual discomfort that became more marked during the following month, with the appearance of angiographic signs of recurrence (occult CNV), justifying a full evaluation and a treatment decision.
VA RE: 20/32 - VA LE: 20/125.
Biomicroscopic Examination
The laser scar was stable and unchanged. A grayish zone was observed on the foveal edge of the scar, extending onto the fovea. Several soft drusen were observed, with no hemorrhage or lipid exudates.
▬The laser scar was hypo-fluorescent with regular margins, which disappeared into the fovea.
▬A zone of moderate, progressive hyper-fluorescence was observed throughout the superior nasal region of the macula with minimal fluorescein leakage. Disseminated area of pinpoint leakage, suggested deep occult CNV with no cysts.
SLO-ICG angiography (Figure 37e and f):
a): Early phase: vast zone of macular and superior temporal hypo-fluorescence crossed by several large choroidal vessels which were in contact with the atrophic laser scar. b): Late phase: more marked hypo-fluorescence, suggesting an oval-shaped juxtafoveal and subfoveal vascularized
PED.
Suggested Diagnosis:
Post-laser recurrence in the form of occult CNV after a
long phase of stability.
Contribution of OCT (Stratus* and Spectralis*)
Stratus* Horizontal Section Stratus* Oblique Section
Section through the center of the fovea: The RPE was raised and irregular in the juxtafoveal and nasal areas. Within and anterior to the RPE, marked increase of retinal thickness with large intraretinal cysts (Figure 38).
The moderately raised, juxtafoveal and nasal vascularized pigment epithelium detachment was well demonstrated from below with cysts. A small amount of subfoveal fluid was also demonstrated (Figure 38).
Diagnosis |
accounts for preservation of central visual acuity. |
The OCT examination confirmed the presence of a mi- |
This recurrence was unusual in that it consisted of |
nor lesion with a fairly extensive but relatively flat jux- |
occult CNV, as confirmed by OCT and angiography. |
tafoveal and subfoveal |
vascularized pigment epithe- |
It was responsible for limited symptoms, as it was |
lium detachment |
with a moderately reflective cavity. |
initially extrafoveal and slowly progressive. |
This lesion therefore corresponded to a late recur- |
OCT confirmed and refined the diagnosis suggested |
rence after laser photocoagulation, which had been |
by angiography and indicated the need for immedi- |
effective for 6 months. The relative foveal sparing |
ate anti-VEGF therapy. |
|
|
|
|
Chapter 8 · Clinical Features and Natural History of AMD on OCT |
|
247 |
8 |
|
|
|
|
|
|
|
|
|
|
|
|
Occult CNV gradually deteriorating and recurring on an old laser scar.
Follow-up by TD-OCT and SD-OCT after anti-VEGF therapy.
Autofluo
|
a |
|
b |
FA |
FA |
SLO-ICG |
SLO-ICG |
Figure 37: Occult choroidal neovascularization: recurrence at an extrafoveal laser scar. VA: 20/32.
a and b): Color and autofluorescence fundus photographs: stable laser scar. Grayish zone on the foveal edge of the scar extending into the fovea.
c and d): Fluorescein angiography: the regular border around the laser scar is no longer seen at the foveal edge. Zone of superior nasal hyper-fluorescence with minimal diffuse leakage and disseminated pinpoint leakage.
e and f): SLO-ICG angiography superior temporal hypo-fluorescence suggesting a juxtafoveal and subfoveal vascularized PED.
a
Recurrence after laser
Cystoid spaces
V-PED
b
SRD
V-PED
…...Laser Scar……
Figure 38: Occult choroidal neovascularization: recurrence at an extrafoveal laser scar. VA: 20/32.
Stratus* horizontal section through the center of the fovea: the RPE is raised and irregular in the juxtafoveal and nasal sectors. Within and anterior to the RPE, marked increase of retinal thickness with large cysts.
Stratus* oblique section: the vascularized PED is clearly visible, moderately prominent, juxtafoveal and nasal, with cysts. Note the presence of a small subfoveal SRF.
248 Chapter 8 · Clinical Features and Natural History of AMD on OCT
CLINICAL CASE No. 09: Progressive Proliferation of Occult CNV
Occult CNV gradually deteriorating and recurring on an old laser scar.
Follow-up by TD-OCT and SD-OCT after anti-VEGF therapy
The response to treatment by monthly intravitreous injections of anti-VEGF (Lucentis*) was monitored with visual acuity, OCT, fluorescein angiography, and ICG angiography.
The decision to inject was made according to the clinical presentation and resulted in an immediate improvement of VA to 20/25 that was maintained throughout the 15 months of follow-up (Figure 39).
8
OCT
By the first follow-up examination, there was reduction of retinal thickness with almost complete resolution of the large intraretinal cysts, but persistence and even enlargement of the inferior foveal and juxtafoveal SRF on the vertical section (Stratus OCT).
The third and fourth intravitreous injections were therefore performed due to persistence of this intraretinal fluid (Figures 39a and b).
The Spectralis* vertical section showed marked improvement with normal retinal thickness, but persistence of numerous bright hyper-reflective spots in the outer layers and at the edge of the inferior SRF (Figures 39b and c).
At the ninth month, the examination appeared to be almost normal with a very flat PED and good visibility of the external limiting membrane and IS/OS interface. Almost all of the outer nuclear layer had become regular despite scattered bright hyper-reflective spots (Figure 39c).
At this Stage
This post-laser recurrence in the form of occult CNV, after a remission interval of six months, evolved very
slowly and progressively with preservation of fairly
good VA due to its initially extrafoveal site.
The intraretinal fluid and cysts resolved slowly in
response to treatment with return of almost normal
morphology after 3 or 4 months (Figure 39).
This improvement persisted for several months, but another recurrence was observed on OCT and an-
However, one month later, the patient experienced a recurrence with no loss of visual acuity but with multiple changes on OCT.
OCT demonstrated accentuation of the PED, a dense hyper-reflective zone anterior to the RPE, disruption of the external limiting membrane, and numerous subfoveal bright hyper-reflective spots at the edge of the recurrent SRF (Figures 39d and 40).
A fifth injection (Macugen*) was therefore performed and was rapidly effective, restoring normal morphology (Figures 39e and 41).
At the last Examination
Fifteen months after the first visit, retinal morphology was almost normal, despite a small amount of subretinal fluid, slight thickening of the IS/OS interface, and several subfoveal alterations of the outer segments with a concomitant decrease of VA to 20/32.
Angiography
Only minor lesions were observed: the area of occult CNV was still visible in the form of several pinpoint leaks with slight diffuse leakage.
On SLO-ICG, the zone of the PED remained dark but had low contrast and was poorly-delineated. The neovascular membrane was barely visible (Figure 39).
giography after 9 months at the monthly follow-up with return of all signs but with no loss of VA. This emphasized the importance of follow-up imaging.
Another IVT injection was again effective, throughout 15 months of follow-up.
This suspension of treatment is probably only tem-
porary. Persistence of the several alterations of the outer retinal layers, bright hyper-reflective spots, and a small SRF indicate the need for long-term follow-up.
Chapter 8 · Clinical Features and Natural History of AMD on OCT |
249 |
8 |
|
|
|
|
CLINICAL CASE No. 09: PROGRESSIVE PROLIFERATION OF OCCULT CNV
Occult CNV gradually deteriorating and recurring on an old laser scar.
Follow-up by TD-OCT and SD-OCT after anti-VEGF therapy.
3 rd month
Fluid
After IVT 3
20/25
Hyper-reflective dots
6 th month
|
20/25 |
After IVT 4 |
|
|
c |
|
9 th month |
20/25
20/25 |
Æ IVT 5 |
|
Stabilization |
15 th month |
20/32
Figure 39: Occult choroidal neovascularization: recurrence on an extrafoveal laser scar. VA: 20/32.
Follow-up during treatment with:
a): improvement, b): stabilization, c): almost complete return to normal,
d): then recurrence requiring another injection, followed by e): stabilization until 15th months later.
250 Chapter 8 · Clinical Features and Natural History of AMD on OCT
CLINICAL CASE No. 09: PROGRESSIVE PROLIFERATION OF OCCULT CNV
Occult CNV gradually deteriorating and recurring on an old laser scar.
Follow-up by TD-OCT and SD-OCT after anti-VEGF therapy.
________________
ENLARGED IMAGES
d
8
Æ IVT 4
20/25
Figure 40: Occult choroidal neovascularization: recurrence at an extrafoveal laser scar. VA: 20/32. d): Recurrence during follow-up of treatment
▬Within and posterior to the RPE: Accentuation of the PED; Irregularity of the RPE.
▬Anterior to the RPE:
Dense hyper-reflective zone;
Disruption of the external limiting membrane; poorly-defined and thickened IS/OS interface; Numerous subfoveal bright hyper-reflective spots on the edge of the recurrent SRF; Poorly-defined and severely altered outer nuclear layer.
Chapter 8 · Clinical Features and Natural History of AMD on OCT |
251 |
8 |
|
|
|
|
CLINICAL CASE No. 09: PROGRESSIVE PROLIFERATION OF OCCULT CNV
Occult CNV gradually deteriorating and recurring on an old laser scar.
Follow-up by TD-OCT and SD-OCT after anti-VEGF therapy.
________________
ENLARGED IMAGES
e
SRD
PED
20/32
Figure 41: Occult choroidal neovascularization: recurrence at an extrafoveal laser scar. VA: 20/32. e): Stabilization at the 15th month: almost normal morphology.
▬Within and posterior to the RPE: Persistence of a wavy, relatively flat PED; Regular band of RPE.
▬Anterior to the RPE: Subretinal fluid;
Slight thickening of the IS/OS interface, but the external limiting membrane is clearly visible; Subfoveal alterations of the outer segments and several bright hyper-reflective spots; Clearly visible and regular outer nuclear layer with good organization of retinal layers.